210
Bioinformatics of the Brain
variations in 77 different miRNAs, spread throughout the miRNA precursors
in various locations.
Novak et al employed single cell transcriptomics using human IPSC (In-
duced pluripotent stem cells) and identified a core network which interacts
with all 19 PD genes [78]. They also showed that this core network is asso-
ciated with key PD signaling pathways. Hemmings and coworkers identified
common and distinct biological pathways for posttraumatic stress disorder,
PD and SCZ in a South African sample using RNA-seq analysis [79].
In a study by Hensman Moss and colleagues, whole blood from two HD
groups was used for RNA-Seq transcriptomic analysis, which discovered dys-
regulated gene sets in the blood of these individuals [80]. Their findings in-
dicate that transcription is disturbed in peripheral cells in HD by similar
mechanism of actions as those in the brain. Using single nucleus RNA-seq,
Lim and colleagues conducted a transcriptome-wide association research for
HD [81]. Their data reveal PRKCE and TPK1 as key genes and link aberrant
cell maturation to glucose and lipid metabolism.
Rare mutations may be partially to blame for the absent MS heritability.
Mescheriakova and colleagues performed whole exome sequencing in hopes of
identifying rare variants associated with the disease [82]. They discovered an
uncommon missense variation in the FKBP6 gene. Esposito and colleagues
performed a whole genome sequencing study of MS patients and healthy con-
trols using DNA and blood samples [83]. They found that in response to in-
flammatory triggers in peripheral monocytes, the activity of GRAMD1B was
reduced in vessel-associated astrocytes of MS lesions, suggesting a potential
role in the modulation of inflammatory response and disease development.
The field of RNA-seq research has also included neuropsychiatric disor-
ders. Mostafavi and coworkers performed whole blood RNA-seq in MDD re-
vealing that there was no substantial single-gene connection [84]. They dis-
covered correlation between MDD and elevated gene expression in the in-
terferon signaling pathway. Their findings are consistent with the theory that
alterations in immunological signaling contribute to the advancement, appear-
ance and persistence of MDD. A more recent study by Fabbri and colleagues
employed whole exome sequencing and genome-wide genotyping to examine
treatment-resistant depression (TRD), which affects 30 % of MDD patients
[85]. They proposed pertinent biological pathways linked to TRD as well as a
fresh methodological strategy for TRD prediction.
As stated before, for some brain disease and disorders a special effort was
made to investigate blood biomarkers. Through the simultaneous measure-
ment of mRNAs, long noncoding RNAs (lncRNAs), miRNAs, and circular
RNAs (circRNAs) in a group of patients, Yang et al. carried out a whole tran-
scriptome investigation using whole blood to identify the molecular networks
in SZC [86]. Their comprehensive analysis identified dysregulated networks
and pathways in SZC. There are also SZC studies that combine microar-
ray and RNA-seq technologies. For instance, Bakewell and colleagues per-
formed exome sequencing and SNP (single nucleotide polymorphism) array to